首页>
外国专利>
Combinations of an Anti-HER2 antibody-drug conjugate and pertuzumab
Combinations of an Anti-HER2 antibody-drug conjugate and pertuzumab
展开▼
机译:抗HER2抗体-药物偶联物和帕妥珠单抗的组合
展开▼
页面导航
摘要
著录项
相似文献
摘要
Combinations of the antibody-drug conjugate trastuzumab-MCC-DM1 and chemotherapeutic agents, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting tumor cell growth, and for treating disorders such as cancer mediated by HER2 and KDR (VEGFR receptor 1). Methods of using such combinations forin vitro,in situ, andin vivodiagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
展开▼